Cardiovascular Risk Differs for Stone Formers With ESKD
Among patients with nephrolithiasis or urolithiasis, the cardiovascular event rate was 74.4 per 1000 person-years.
Diagnosis & Disease Information
Generic Version of Thiola Now Available
Tiopronin is indicated for the prevention of cystine stone formation in patients with severe homozygous cystinuria who are unresponsive to treatment with high fluid intake, alkali, and diet modification.
Pregnancy Found to Increase Risk of First-Time Symptomatic Kidney Stones
The risk for a first-time symptomatic kidney stone begins to increase in the second trimester and peaks 0 to 3 months after delivery, a study found.
Urologists Are Performing More Initial Renal Access Procedures for PCNL
Urologist-gained renal access for percutaneous nephrolithotomy is associated with significantly lower 90-day rates of hospital readmission and blood transfusion compared with radiologist-gained access, a study found.
FDA Investigating Infections Tied to Reprocessing Urological Endoscopes
More than 450 medical device reports of patient infections, potential contamination recorded from Jan. 1, 2017, to Feb. 20, 2021
Sodium Bicarbonate May Mitigate Calcium Phosphate Stone Risk in CKD
Oral sodium bicarbonate therapy given to patients with chronic kidney disease increases urinary pH but also increases urinary citrate levels, which may mitigate the risk for calcium phosphate stone formation.
Kidney Stones Found to Increase Stroke Risk
Kidney stones were associated with different degrees of risk for ischemic than hemorrhagic stroke, according to a recent meta-analysis.
Kidney Stones Linked With Osteoporosis, Fractures
Bone loss in patients with kidney stone disease, particularly in men, has been underappreciated in clinical practice, according to investigators.
Primary Hyperparathyroidism Underdiagnosed Among Kidney Stone Formers
Patients with kidney stones who visited both a nephrologist and a urologist had a 6.6-fold higher likelihood of receiving testing for primary hyperparathyroidism, according to a study of veterans.
Tolvaptan Lowers Kidney Stone Risk in ADPKD
Tolvaptan improves the urinary lithogenic risk profile of patients with autosomal dominant polycystic kidney disease, according to researchers.
- Loading...
Loading...
Next post in Kidney Stones
Loading... 
Loading...